Journal Article Review Epublish 50 citations
PubMed: 35663580 DOI: 10.3389/fnagi.2022.827263
Neuroinflammation: A Possible Link Between Chronic Vascular Disorders and Neurodegenerative Diseases.
Front Aging Neurosci 14:827263
Authors: Emmanuel Moyse, Slavica Krantic, Nesrine Djellouli, Sébastien Roger, Denis Angoulvant, Camille Debacq, Victoire Leroy, Bertrand Fougere, Amal Aidoud
Affiliations
- University of Tours, EA4245, Transplantation, Immunologie, Inflammation, Tours, France.
- Centre de Recherche Saint-Antoine (CRSA), Immune System and Neuroinflammation Laboratory, Hôpital Saint-Antoine, Inserm U938, Sorbonne Université, Paris, France.
- Department of Cardiology, Tours University Hospital, Tours, France.
- Division of Geriatric Medicine, Tours University Hospital, Tours, France.
- University of Tours, EA7505, Education, Ethics, Health, Tours, France.
Abstract
Various age-related diseases involve systemic inflammation, i.e. a stereotyped series of acute immune system responses, and aging itself is commonly associated with low-grade inflammation or inflamm'aging. Neuroinflammation is defined as inflammation-like processes inside the central nervous system, which this review discusses as a possible link between cardiovascular disease-related chronic inflammation and neurodegenerative diseases. To this aim, neuroinflammation mechanisms are first summarized, encompassing the cellular effectors and the molecular mediators. A comparative survey of the best-known physiological contexts of neuroinflammation (neurodegenerative diseases and transient ischemia) reveals some common features such as microglia activation. The recently published transcriptomic characterizations of microglia have pointed a marker core signature among neurodegenerative diseases, but also unraveled the discrepancies with neuroinflammations related with acute diseases of vascular origin. We next review the links between systemic inflammation and neuroinflammation, beginning with molecular features of respective pro-inflammatory cells, i.e. macrophages and microglia. Finally, we point out a gap of knowledge concerning the atherosclerosis-related neuroinflammation, which is for the most surprising given that atherosclerosis is established as a major risk factor for neurodegenerative diseases.
MeSH
Aging, Macrophages, Atherosclerosis, Neurodegenerative Diseases, Astrocytes, Microglia
Cited by
- Comprehensive Analysis of Titanium Oxide Nanoparticle Size and Surface Properties on Neuronal PC-12 Cells: Unraveling Cytotoxicity, Dopaminergic Gene Expression, and Acetylcholinesterase Inhibition. J Xenobiot, 2023
- Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy. J Clin Med, 2023
- Bergaptol Alleviates LPS-Induced Neuroinflammation, Neurological Damage and Cognitive Impairment via Regulating the JAK2/STAT3/p65 Pathway. J Inflamm Res, 2022
- Dietary Fats and Depressive Symptoms in Italian Adults. Nutrients, 2023
- Bergaptol, a Major Furocoumarin in Citrus: Pharmacological Properties and Toxicity. Molecules, 2024
- Anthraquinones and Aloe Vera Extracts as Potential Modulators of Inflammaging Mechanisms: A Translational Approach from Autoimmune to Onco-Hematological Diseases. Molecules, 2025
- Role of Microglia in Herpesvirus-Related Neuroinflammation and Neurodegeneration. Pathogens, 2022
- A Novel Aryl Hydrocarbon Receptor Antagonist HBU651 Ameliorates Peripheral and Hypothalamic Inflammation in High-Fat Diet-Induced Obese Mice. Int J Mol Sci, 2022
- Sentinels of neuroinflammation: the crucial role of myeloid cells in the pathogenesis of gliomas and neurodegenerative diseases. J Neuroinflammation, 2024
- Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders. Cells, 2024
- Rethinking neurodegenerative diseases: neurometabolic concept linking lipid oxidation to diseases in the central nervous system. Neural Regen Res, 2023
- Anti-neuroinflammatory therapy for non-pulsatile tinnitus in patients with sinus vascular anomalies: preliminary result on two cases. Front Neurol, 2025
- Periodontitis: A Plausible Modifiable Risk Factor for Neurodegenerative Diseases? A Comprehensive Review. Int J Mol Sci, 2024
- The Hallmarks of Ageing in Microglia. Cell Mol Neurobiol, 2025
- Gut-Brain Axis: Focus on Sex Differences in Neuroinflammation. Int J Mol Sci, 2024
- Microglia Depletion Attenuates the Pro-Resolving Activity of the Formyl Peptide Receptor 2 Agonist AMS21 Related to Inhibition of Inflammasome NLRP3 Signalling Pathway: A Study of Organotypic Hippocampal Cultures. Cells, 2023
- Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation. Front Cell Neurosci, 2025
- Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis. J Pers Med, 2022
- An Update on Toll-like Receptor 2, Its Function and Dimerization in Pro- and Anti-Inflammatory Processes. Int J Mol Sci, 2023
- The Role of Neuroinflammation in the Comorbidity of Psychiatric Disorders and Internal Diseases. Healthcare (Basel), 2025